MedPath
NMPA Approval

Telmisartan Tablets

国药准字H20253064

January 2, 2025

Drug Information

替米沙坦片

片剂

80mg

化学药品

January 2, 2025

Company Information

Applicant Company

浙江省临海市汛桥

Manufacturing Company

浙江省临海市汛桥

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替米沙坦片 - NMPA 批准文号 | MedPath